Delivery Order SPE2DB24D1205-SPE2DB24FCUBP
Award Date
8/26/24
Potential Completion Date
9/17/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,249.20, is a Firm Fixed Price Delivery Order for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a cancer medication. The contract has an ultimate completion date of October 2, 2024. Amerisourcebergen, as one of the largest pharmaceutical distributors in the United States, leverages its extensive...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,606,804 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price ceiling value of $1,754.58 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this delivery order contract without any set-aside...
This federal contract award, valued at $1,754.58, was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with no set-aside designation, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $5,263.74 and is for the delivery of 4564821326 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 26, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical...
This is a delivery order under contract SPE2DB22D2206/SPE2DB25FDX33, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,088.81 firm fixed-price contract is for the supply of the medication ZOLADEX 10.8 MG IMPLANT SYRNS. The period of performance runs through November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $1,859.50. The contract is not set aside and will deliver ZOLADEX 10.8 MG IMPLANT SYRNS to the government. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,754.58 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of March 15, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period...
This federal contract award, valued at $1,873.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of May 10, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,985.82 firm fixed-price delivery order contract is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a medical device. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,406,797 units of the ZOLADEX 10.8 MG IMPLANT SYRNS pharmaceutical product. The $1,754.58 order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contracts from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and...